Bessemer Group’s Medifast MED Stock Holding History

Bessemer Group’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-79	Closed	-$3K	–	2096
2024 Q1	$3K	Buy	+79	New	+$3.83K	﹤0.01%	1869
2023 Q4	–	Sell	-15	Closed	-$1K	–	2224
2023 Q3	$1K	Hold	15	–	–	﹤0.01%	2092
2023 Q2	$1K	Buy	+15	New	+$1.33K	﹤0.01%	2181
2018 Q4	–	Sell	-1,600	Closed	-$354K	–	2012
2018 Q3	$354K	Sell	1,600 -2,200	-58%	-$446K	﹤0.01%	855
2018 Q2	$609K	Sell	3,800 -11,900	-76%	-$1.52M	﹤0.01%	708
2018 Q1	$1.47M	Sell	15,700 -2,100	-12%	-$157K	0.01%	477
2017 Q4	$1.24M	Sell	17,800 -7,000	-28%	-$464K	﹤0.01%	549
2017 Q3	$1.47M	Hold	24,800	–	–	0.01%	533
2017 Q2	$1.03M	Hold	24,800	–	–	﹤0.01%	656
2017 Q1	$1.1M	Hold	24,800	–	–	﹤0.01%	677
2016 Q4	$1.03M	Hold	24,800	–	–	﹤0.01%	702
2016 Q3	$937K	Buy	+24,800	New	+$889K	﹤0.01%	624
2016 Q2	–	Sell	-14	Closed	–	–	1390
2016 Q1	$0	Buy	+14	New	+$409	﹤0.01%	1587

Other funds holding MED

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Bessemer Group's MED Position: Q2 2024 in Review

Bessemer Group sold out of Medifast (MED) in Q2 2024, closing a stake of 79 shares — an estimated $3K sold.

Bessemer Group first reported a position in MED in Q1 2016 and held it in 13 quarters. The position peaked at $1.47M in Q3 2017. 158 funds tracked by Wall St. Rank hold MED as of Q2 2024.

Bessemer Group reported no remaining Medifast position as of Q2 2024 after selling out during the quarter.
Bessemer Group sold 79 Medifast shares in Q2 2024, an estimated $3K.
Bessemer Group first reported a position in Medifast in Q1 2016 and held it in 13 quarters.
Bessemer Group's Medifast position peaked at $1.47M in Q3 2017.
158 funds tracked by Wall St. Rank held Medifast as of Q2 2024.

Based on Bessemer Group's 13F filing for Q2 2024, filed 13 Aug 2024.